Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
intranasal carbetocin (ACP-101) / Acadia Pharma
NCT06173531: Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome	Recruiting	3	170	Europe, Canada, US	Carbetocin, ACP-101, Placebo	ACADIA Pharmaceuticals Inc.	Hyperphagia in Prader-Willi Syndrome	05/26	06/26
NCT06420297: OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome	Enrolling by invitation	3	160	Canada, US	Carbetocin, ACP-101	ACADIA Pharmaceuticals Inc.	Hyperphagia in Prader-Willi Syndrome	05/29	06/29